文献速递肺栓塞与肺血管病

慢性血栓栓塞性肺动脉高压患者生存趋势:一项观察性研究

Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.
PubMed 文献 · Eur Respir J · 2025-07-14

该回顾性研究分析834例CTEPH患者,按1980-1999、2000-2010、2010-2023三个时代分组,发现未接受CTEPH治疗比例从65%降至3%,多模式治疗从0%升至58%,5年生存率从68%升至93%,全因死亡风险显著下降。

要点

  • CTEPH患者5年生存率从早期68%提升至当前93%。
  • 未治疗比例从65%降至3%,多模式治疗从0%升至58%。
  • 当前时代较早期全因死亡调整HR为0.130(95%CI 0.067-0.254)。

核心结论

  • 近几十年来CTEPH患者长期预后显著改善。

研究设计与样本

  • 主要终点为全因死亡率,采用多变量Cox比例风险模型调整混杂因素。

主要发现

  • 早期、中期和当前时代分别纳入95、210和529例患者。
  • 未接受CTEPH治疗的患者比例从早期65%降至中期36%和当前3%。
  • 多模式治疗采用率从0%增至58%。
  • Kaplan-Meier分析显示总生存率显著改善(log-rank p<0.001)。
  • 5年生存率从早期68%提升至中期85%和当前93%。

关键数值与推荐

  • 早期 vs 中期全因死亡调整HR为0.291(95%CI 0.154-0.550;p<0.001)。
  • 中期 vs 当前全因死亡调整HR为0.447(95%CI 0.249-0.804;p=0.007)。
  • 早期 vs 当前全因死亡调整HR为0.130(95%CI 0.067-0.254;p<0.001)。

临床怎么用

  • CTEPH治疗普及和多模式治疗与生存改善相关,应积极采用现有治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment options for patients with chronic thromboembolic hypertension (CTEPH) have increased over the past decade. However, it is unknown whether the outcomes of patients with CTEPH have changed as well. METHODS: This retrospective study analysed the data of 834 patients with CTEPH, categorised into early (April 1980-December 1999), middle (January 2000-September 2010) and current (October 2010-December 2023) eras. The primary end-point was all-cause mortality. Multivariable Cox proportional hazards models were used to assess changes in all-cause mortality after adjusting for confounding variables. RESULTS: 95, 210 and 529 patients were from the early, middle and current eras, respectively. The proportion of patients who did not receive CTEPH therapy decreased from 65% in the early era to 36% and 3% in the middle and current eras, respectively. Meanwhile, the adoption of multimodal treatment increased from 0% to 58% over time. The Kaplan-Meier analysis revealed significant improvements in overall survival (log-rank p<0.001). The 5-year survival rates improved from 68% in the early era to 85% and 93% in the middle and current eras, respectively. The adjusted hazard ratios for mortality were 0.291 (95% CI 0.154-0.550; p<0.001) for the early versus middle era, 0.447 (95% CI 0.249-0.804; p=0.007) for the middle versus current era and 0.130 (95% CI 0.067-0.254; p<0.001) for the early versus current era. CONCLUSION: The long-term prognosis of patients with CTEPH has significantly improved in recent decades.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kiko T, Asano R, Yoshikawa Y, et al. Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study. Eur Respir J. 2025. PMID: 40049724. doi:10.1183/13993003.02268-2024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。